Molecular lesion data in LR-MDS prognostic models reduce the significance of traditional parameters like bone marrow blast percentage. Molecular data altered risk stratification for 30% of patients, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback